The Latest News, Data & Insight From The World Of Genetic Testing

Today, Concert Genetics released a complete set of medical policies integrated with its catalog of more than 160,000 genetic testing products. Now, anyone can search by product name or Genetic Testing Unit (GTU) to instantly locate the coverage criteria for any genetic test. “For too long, systemic barriers, such as confusing, conflicting, or inconclusive medical […]

Solution delivers payment accuracy and billing compliance in one of Medicare’s highest growth segments NASHVILLE, Tenn. (Aug 26, 2021) – Concert Genetics has launched a genetic testing payment accuracy and compliance solution for Medicare and Medicare Advantage plans. The offering extends Concert’s innovative solution for commercial plans, providing unparalleled test identification, coding consistency, and automated […]

Unique IDs for more than 160,000 genetic testing products released for use in test ordering, authorization, coverage, payment, and clinical decision support NASHVILLE, Tenn. (June 24, 2021) – Concert Genetics has released its comprehensive genetic test identification system for use in the market, enabling a level of automation in test ordering, coverage, payment and clinical […]

Concert links 160,000 genetic tests to coverage criteria, automates accurate payment, and supports high-value clinical test ordering NASHVILLE, Tenn. (June 9, 2021) – The U.S. Patent and Trademark Office has issued Concert Genetics patent US10,896,405B1 for innovative methods that enable real-time coverage determination and accurate reimbursement of genetic tests, the company announced today. As the patent […]

Partnership combines scalable technology infrastructure with proven clinical services to help meet the growing demand for genetic care MINNEAPOLIS and NASHVILLE, Tenn. (March 31, 2021) – GeneMatters, a leading provider of telegenetics services and software, and Concert Genetics, a healthcare technology company providing the digital infrastructure for genetic testing management, today announced a partnership to help […]

Concert Genetics Benefit Program combines policy, payment integrity, and a preferred laboratory network to improve quality, reduce complexity, and eliminate manual effort NASHVILLE, Tenn. (Dec. 21, 2020) – Concert Genetics today unveiled the Concert Genetics Benefit Program, an end-to-end genetic testing management solution that enables health plans to provide members with access to high-quality, clinically […]

ALEXANDRIA, Va. and NASHVILLE, Tenn. (December 15, 2020) – The Burgess Group (“Burgess”), a HealthEdge company, an innovative payment integrity software company focused on improving healthcare payment operations through technology, has selected Concert Genetics to deliver genetic testing claim edits within the Burgess Source® claims payment automation and business intelligence platform. The solution integrates Concert’s […]

Partnership Seeks to Lower Barriers to Evidence-Based Molecular Oncology Care by Extending Trapelo’s Decision Support Solutions Through Concert’s Network of Labs and Health Plans BURLINGTON, Ma. and NASHVILLE, Tenn. (Dec. 10, 2020) – Concert Genetics and Trapelo Health announced today that they have partnered to provide a streamlined, integrated solution that will expand access to evidence-based, […]

As mentioned in an earlier blog post, the Genetic Health Information Network Summit convenes leading from voices across healthcare to share practical challenges and actionable solutions to enable precision medicine. An issue frequently discussed in past Summits (summarized here) is the difficulty of integrating genetics into the clinical workflow. A dizzying array of genetic tests […]

Companies Provide Pre-payment Solution to Improve Coding and Billing Accuracy BEDMINSTER, NJ and NASHVILLE, TN – September 24, 2020 – Zelis, the healthcare industry’s leading claims cost and payments optimization platform with superior technology and solutions to price, pay and explain claims, and Concert Genetics, a technology company dedicated to advancing precision medicine, have launched […]

NASHVILLE, Tenn. (April 1, 2020) – Concert Genetics, a technology company dedicated to advancing precision medicine, today announced the publication of real-world data on utilization and coding variability in medical claims for Next-Generation Sequencing (NGS)-based diagnostic tests. The study was done in collaboration with Merck, known as MSD outside the United States and Canada, and […]

We are pleased to offer this upcoming webinar in collaboration with Burgess and RJ Health. Precision Medicine for Health Plans: Managing coverage and reimbursement amidst the rapid evolution of genetic testing and targeted therapies Wednesday, Feb. 13th 1:00-2:00 pm CT Register here The pace of advancement in genetics and precision medicine is staggering. Today, there […]

The Concert Platform consolidates multiple workflows to streamline communication between clinicians, provider organizations, laboratories and health plans NASHVILLE, Tenn. (Feb. 8, 2018) – Concert Genetics, a technology and managed services company advancing precision medicine, has enhanced its industry leading genetic test order management system to better meet the needs of stakeholders across the healthcare system. […]

Latest update adds insurance coverage information and other enhancements to the market’s leading genetic test order management platform Earlier today, we announced the release of the latest version of our genetic test ordering management system – The Concert Platform (formerly GeneConnect®) – adding compelling new capabilities to a platform used by leading hospitals and health […]

Long-time users of Concert Genetics know we offer a free tool that allows users to search and compare tests from across the entire U.S. clinical genetic testing market. In fact, it’s the #1 genetic test search and comparison tool available. So, what’s new? Today, we released an enhanced version with more (and better) ways to search […]

Investment capital will enable Concert to expand its offerings focused on the data and digital infrastructure for reliable and efficient management of genetic testing NASHVILLE, Tenn. (Jan. 8, 2018) – Concert Genetics, Inc., announced today it has completed a growth capital financing round with a structured facility led by Deerfield Management. The funds will be […]

Healthcare leaders organize summit on the data and digital infrastructure needed to enable precision medicine NASHVILLE, Tenn. (May 18, 2017) – Healthcare information technology firm Concert Genetics, in collaboration with leaders from across genetics and healthcare, today announced the first Genetic Health Information Network Summit will take place Sept. 26-27, 2017, in Nashville, Tennessee. The […]

At Concert Genetics, we are believers in the promise of precision medicine. In particular, we believe in the role genetics can play in transforming the healthcare system. We’re also pragmatists. Two decades into the genetic revolution, the practical barriers to integrating genetics into the delivery of clinical care are undeniable. The fact is, the infrastructure […]

By Rob Metcalf and Mark Harris, PhD Today we officially launched our company’s new name and brand. We are now Concert Genetics. This is a defining moment for our organization. As we continue to grow, and genetic testing becomes an even more prominent part of the healthcare industry, it’s essential we present a clear picture […]

Healthcare information technology firm working to connect and enable precision medicine NASHVILLE, Tenn. (March 1, 2017) – Healthcare information technology firm NextGxDx Inc. has announced that it is now Concert Genetics. The change is intended to reflect the company’s mission of providing data-driven tools to connect, unify and simplify the world of genetic testing for […]

By Rob Metcalf Since its foundation in 2010, Concert Genetics has delivered innovation, transparency and standardization to the way clinicians, laboratories, healthcare provider organizations and health insurers navigate the complex and growing field of genetic testing. I’m thrilled to have the opportunity to join Concert Genetics for the next phase of the journey. Mark and I have […]

By Mark Harris, PhD   It’s an exciting day for Concert Genetics. Today we announce – and officially welcome – Rob Metcalf as our new Chief Executive Officer. I couldn’t be happier to have Rob on our team. As we move from a startup to a growth-phase company, he brings the right skill set and […]

NASHVILLE, Tenn. (July 8, 2016) — Mark Harris, Ph.D., today announced Rob Metcalf has succeeded him as chief executive officer of Concert Genetics (*formerly NextGxDx). Harris, who founded the healthcare information technology company in 2010, has elected to take a new leadership position, chief innovation officer, where his primary focus will be developing the next […]

By: David Shifrin, PhD Science Writer, Filament Life Science Communications We talk a lot about the value of big data in genetics testing and the importance of having large-scale studies for things like genome-wide association. We don’t, however, talk as much about some of the problems that arise out of huge datasets. Aside from computational challenges, […]